Whether for cosmetic augmentation or reconstructive purposes, women who elect to undergo surgery to receive breast implants do so under the notion that the implants are safe and won’t cause undue harm to their bodies.
In July 2019, at the FDA’s request, breast implant manufacturer Allergan issued a worldwide voluntary recall of its Biocell® textured breast implants and tissue expanders due to claims of women with the implants developing breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare form of non-Hodgkin’s lymphoma.
Anaplastic Large Cell Lymphoma Symptoms
In its initial stages, ALCL symptoms can include:
Painless swelling of lymph nodes
Loss of appetite
It’s common for women to also experience pain, lumps, fluid buildup and swelling at implant sites prior to a diagnosis.
FDA data shows that the rare cancer BIA-ALCL occurs more frequently in women with textured surface breast implants than implants with smooth surfaces. Studies are ongoing to determine why BIA-ALCL is more prevalent with textured breast implants. In some cases, the cancer seems to be associated with a certain bacterial infection.
Motley Rice LLC, a South Carolina Limited Liability Company, is engaged in the New Jersey practice of law through Motley Rice New Jersey LLC. Esther Berezofsky is the attorney responsible for New Jersey practice.
Working with us
Wondering what happens when you submit a form or give us a call? We spend time gathering information from you, and your initial call is always free.
- Chronology of events
- Pertinent documents